Galera Therapeutics Stock Profit Margin
| GRTXDelisted Stock | USD 2.58 0.19 6.86% |
Galera Therapeutics fundamentals help investors to digest information that contributes to Galera Therapeutics' financial success or failures. It also enables traders to predict the movement of Galera Pink Sheet. The fundamental analysis module provides a way to measure Galera Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Galera Therapeutics pink sheet.
Galera |
Galera Therapeutics Company Profit Margin Analysis
Galera Therapeutics' Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
CompetitionBased on the latest financial disclosure, Galera Therapeutics has a Profit Margin of 0.0%. This is 100.0% lower than that of the Biotechnology sector and 100.0% lower than that of the Health Care industry. The profit margin for all United States stocks is 100.0% lower than that of the firm.
Galera Profit Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Galera Therapeutics' direct or indirect competition against its Profit Margin to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Galera Therapeutics could also be used in its relative valuation, which is a method of valuing Galera Therapeutics by comparing valuation metrics of similar companies.Galera Therapeutics is currently under evaluation in profit margin category among its peers.
Galera Fundamentals
| Return On Equity | -10.63 | ||||
| Return On Asset | -0.59 | ||||
| Current Valuation | 146.68 M | ||||
| Shares Outstanding | 54.39 M | ||||
| Shares Owned By Insiders | 36.15 % | ||||
| Shares Owned By Institutions | 18.95 % | ||||
| Number Of Shares Shorted | 2.12 M | ||||
| Price To Earning | (0.78) X | ||||
| Price To Book | 29.39 X | ||||
| EBITDA | (46.69 M) | ||||
| Net Income | (59.08 M) | ||||
| Cash And Equivalents | 52.01 M | ||||
| Cash Per Share | 1.94 X | ||||
| Total Debt | 152.3 M | ||||
| Debt To Equity | 0.09 % | ||||
| Current Ratio | 5.02 X | ||||
| Book Value Per Share | (2.48) X | ||||
| Cash Flow From Operations | (44.85 M) | ||||
| Short Ratio | 1.16 X | ||||
| Earnings Per Share | (0.91) X | ||||
| Price To Earnings To Growth | (0.02) X | ||||
| Target Price | 0.5 | ||||
| Beta | 2.03 | ||||
| Market Capitalization | 7.89 M | ||||
| Total Asset | 26.14 M | ||||
| Retained Earnings | (437.41 M) | ||||
| Working Capital | 16.67 M | ||||
| Current Asset | 36.65 M | ||||
| Current Liabilities | 5.37 M | ||||
| Net Asset | 26.14 M |
About Galera Therapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Galera Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Galera Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Galera Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Consideration for investing in Galera Pink Sheet
If you are still planning to invest in Galera Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Galera Therapeutics' history and understand the potential risks before investing.
| Stocks Directory Find actively traded stocks across global markets | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |